These variants lead to altered transcriptional activity and affect the DNA-binding ability of the LMX1B protein, finally resulting in multisystem symptoms in patients with NPS (Dreyer et al., 1998; Dreyer, 2000). Here, LMX1B is linked to nail-patella syndrome.